Baqsimi (glucagon) is a prescription drug that’s used to help treat emergency episodes of low blood sugar in adults and some children with diabetes. Baqsimi comes as a powder for nasal inhalation.
For this use, doctors may prescribe Baqsimi to adults as well as children 4 years and older. Both type 1 and type 2 diabetes are long-term conditions. If you and your doctor agree that Baqsimi is safe ...
Baqsimi (glucagon) is a brand-name drug that’s prescribed for severe low blood sugar in adults and some children with diabetes. Baqsimi comes as a nasal powder. It’s used as needed in a medical ...
Each Baqsimi device includes 1 dose of glucagon and cannot be refused. The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of ...
The EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi as the first needle-free treatment for severe low blood sugar levels (hypoglycaemia) in diabetics in the EU ...
Eli Lilly announced Monday morning that it is divesting Baqsimi, its low blood sugar rescue treatment, to Amphastar Pharmaceuticals for $500 million. The boards of directors at both companies have ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
(RTTNews) - Pharma major Eli Lilly and Company (LLY) said on Monday that it has inked a deal with Amphastar Pharmaceuticals, Inc. (AMPH), to divest BAQSIMI, the dry nasal spray to treat very low blood ...
Eli Lilly offloads innovative hypoglycemia nasal spray, Baqsimi, to Amphastar Pharmaceuticals bolstering Amphastar's diabetes portfolio. Eli Lilly has announced plans to sell Baqsimi, its innovative ...
24don MSN
Amphastar forecasts BAQSIMI revenue flat to up low single digits, with 3% list price increase
Q1 2026 Management view Dan Dischner (Senior Vice President of Human Resources & Corporate Communication) said Q1 reflected “a return to growth, driven primarily by contributions from recent product ...
Baqsimi (glucagon) is a prescription drug that’s used to treat severely low blood sugar levels. The drug comes as nasal powder. It’s usually given as a one-time dose. Baqsimi is used in adults and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results